Ganiraju Manyam, Ph.D.

2009 George Mason University, Washington, DC 
Bioinformatics Biology, Oncology, Molecular Biology
"Ganiraju Manyam"


Sign in to add mentor
Ancha Baranova grad student 2009 George Mason
 (Global patterns of changes in the gene expression associated with genesis of cancer.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Lee MS, McGuffey EJ, Morris JS, et al. (2016) Association of CpG island methylator phenotype and EREG/AREG methylation and expression in colorectal cancer. British Journal of Cancer
Jarrar M, Behl S, Manyam G, et al. (2016) Cytochrome allelic variants and clopidogrel metabolism in cardiovascular diseases therapy. Molecular Biology Reports
Rao A, Manyam G, Rao G, et al. (2016) Integrative Analysis of mRNA, microRNA, and Protein Correlates of Relative Cerebral Blood Volume Values in GBM Reveals the Role for Modulators of Angiogenesis and Tumor Proliferation. Cancer Informatics. 15: 29-33
Zoh RS, Mallick B, Ivanov I, et al. (2016) PCAN: Probabilistic correlation analysis of two non-normal data sets. Biometrics
Ceccarelli M, Barthel FP, Malta TM, et al. (2016) Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 164: 550-563
Ye Q, Xu-Monette ZY, Tzankov A, et al. (2015) Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma. Oncotarget
Xu-Monette ZY, Dabaja BS, Wang X, et al. (2015) Clinical features, tumor biology, and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell lymphoma patients treated with rituximab-CHOP. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc
Guinney J, Dienstmann R, Wang X, et al. (2015) The consensus molecular subtypes of colorectal cancer. Nature Medicine
Deng L, Xu-Monette ZY, Loghavi SN, et al. (2015) Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: A report from the International PTL Consortium. Leukemia
Liu Z, Xu-Monette ZY, Cao X, et al. (2015) Prognostic and biological significance of survivin expression in patients with diffuse large B-cell lymphoma treated with rituximab-CHOP therapy. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc
See more...